Ascension St. Vincent’s Riverside has reached a major milestone in its minimally invasive heart program. The cardiology team completed its 2000th transcatheter aortic valve replacement (TAVR).
TAVR is a treatment to replace a narrowed aortic valve that doesn't open fully, which is called aortic valve stenosis. This condition blocks or slows blood flow from the heart to the body. The procedure is a minimally invasive alternative to open-heart valve surgery. It can help ease chest pain, shortness of breath and other symptoms.
“Ascension St. Vincent’s is focused on providing premier heart care, and this milestone demonstrates the impact that our cardiologists are making in our community,” said Scott Kashman, President & CEO of St. Vincent’s Riverside. “We prioritize compassionate and quality care for our heart patients and seek to provide the best outcomes for every person who trusts us with their care.”
